Meanwhile, higher education level, attention to the disease and complications, reducing chemotherapy damage, adequate nutrient intake, relieving symptoms, controlling depression, and maintaining immunity and the ability to perform activities of daily living may all be the positive factors that protect against frailty in patients with SMARCA4-UT. This evidence concerns the gene SMARCA4 and depressive disorder.